Important Announcement!
As the U.S. continues to re-open from COVID-19, the Partners Program Advisory Board has determined that all programs hosted in 2021 will remain virtual as planned. In-person programs will resume in 2022. Please contact Allison Lipps at alipps@ihtc.org with any questions.
Online Education
- Home
- Online Education
Important Note
You will need to login first in order to enroll or view an activity. Login Here
*Note: ✔ = Contact Hours Provided AND ✖ = No Contact Hours Provided
A School Nurse's Guide to Bleeding Disorders: Hemophilia
- Credits: 0.75 (ANCC)
- Expiration Date: March 4, 2022
A School Nurse's Guide to Bleeding Disorders: Hemophilia Details
Activity Number and Title
19CE101 - A School Nurse's Guide to Bleeding Disorders: Hemophilia
Purpose Statement
This online learning activity aims to enable the learner to develop basic knowledge and skills regarding etiology, inheritance, severity, and treatment of hemophilia, recognition of hemophilia symptoms, and use of strategies to promote a safe and positive learning environment.
Educational Objectives
- Dispel common misconceptions about hemophilia
- Review basic information about the etiology, inheritance, and severity of hemophilia
- Identify prevalent locations and symptoms of joint and muscle bleeding in hemophilia
- Describe hemophilia treatment strategies and medications utilized and avoided in hemophilia management
- Discuss guidelines for participation in physical activity and sports by persons with hemophilia
- Integrate reasonable accommodations in the school setting to promote a safe and positive learning environment for the student with hemophilia
- Explain the role of the Hemophilia Treatment Center as a resource for support for schools attended by a student with hemophilia
Target Audience
Nurses and nurse practitioners who practice in schools attended by a student with hemophilia. It may also be helpful to teachers, physical education and sports coaches, administrators, guidance counselors, and other educators and healthcare professionals needing an introduction to school related considerations in hemophilia.
Topics/Content
The online learning activity targets school nurses, nurse practitioners, and other school personnel who require basic knowledge and skill to effectively practice and teach in schools attended by a student with hemophilia. This involves debunking common myths that persist about hemophilia and replacing those myths with factual information concerning the etiology, inheritance, severity, and treatment of hemophilia. It includes information on identifying prevalent locations and symptoms of bleeding in hemophilia. Finally, the activity reviews strategies that may be implemented in the school setting to promote a safe and positive learning environment for the student with hemophilia.
Faculty w/ credentials
- Lisa Bowman, RN, BSN, ASN
- Molly Simmons, RN, BSN
Date of Original Release
March 4, 2020
Expiration Date
5:00 PM Eastern, March 4, 2022
Method of Participation
The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better.
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 0.75 contact hours under ANCC criteria.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Best Transition Practices for Adolescents and Young Adults with Sickle Cell Disease
- Credits: 0.5 (ACCME), 0.5 (ANCC)
- Expiration Date: July 8, 2022
Best Transition Practices for Adolescents and Young Adults with Sickle Cell Disease Details
Activity Number and Title
21HT50947 - Best Transition Practices for Adolescents and Young Adults with Sickle Cell Disease
Release Date
July 8, 2021
Expiration Date
5:00 PM Eastern, July 8, 2022
The estimated time to complete this activity is 30 minutes.
Purpose Statement
The purpose of this activity is to enable the learners to increase knowledge of the care needs of adolescents and young adults (AYAs), the emotional and social development of adolescence, the six core elements of a transition program, and the emotional/social milestones that should be addressed in a transition program for AYAs living with sickle cell disease (SCD).
Activity Description
This online learning activity is focused on improving health outcomes for adolescents and young adults (AYAs) with sickle cell disease (SCD) by improving transition programs and services available for these individuals. The activity will review the emotional and social development of adolescence. It will also discuss the health risks associated with transition among AYAs living with SCD. The module differentiates the pediatric and adult models of care, and examines the six core elements of transition programs, as derived from www.GotTransition.org. Finally, the activity will discuss the medical, social, and educational milestones that should be addressed in transition programs for AYAs with SCD.
Target Audience
This enduring material is intended for physicians, physician assistants, nurses, nurse practitioners, and other health care providers who treat adolescents and young adults with sickle cell disease and wish to improve outcomes associated with the transition from pediatric to adult care for these patients.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Review emotional and social development of adolescence
- Identify health risks associated with transition among adolescents and young adults (AYAs) living with sickle cell disease (SCD)
- Differentiate pediatric and adult models of sickle cell care
- Discuss the six core elements of a transition program
- Describe the medical, social, and educational milestones that should be addressed in a transition program for AYAs living with SCD
Faculty
- Emily Riehm Meier, MD, MSHS
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid from 5/1/2021 to 5/2/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202573.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Comprehensive Care of Adolescents and Young Adults with Sickle Cell Disease
- Credits: 1 (ACCME),1.0 (ANCC), 1 (AAPA)
- Expiration Date: July 8, 2022
Comprehensive Care of Adolescents and Young Adults with Sickle Cell Disease Details
Activity Number and Title
21HT50948 - Comprehensive Care of Adolescents and Young Adults with Sickle Cell Disease
Release Date
July 8, 2021
Expiration Date
5:00 PM Eastern, July 8, 2022
The estimated time to complete this activity is 60 minutes.
Purpose Statement
The purpose of this activity is to enable the learner to gain knowledge necessary to better manage the comprehensive care of adolescents and young adults with sickle cell disease, with the aim of improving health outcomes among these individuals.
Activity Description
This online educational activity covers screening tests that are important in the care of adolescent and young adults (AYAs) with sickle cell disease and the most commonly used medications in this patient group. It also covers reproductive health considerations of AYAs with sickle cell disease, including the need for contraception, the existing knowledge gaps, and the epidemiology and management of priapism. Finally, the activity addresses practical pain management strategies in AYAs with sickle cell disease.
Target Audience
This enduring material is intended for physicians, physician assistants, nurses, nurse practitioners, and other health care providers who treat persons with sickle cell disease (SCD) and wish to improve comprehensive care services provided to adolescents and young adults (AYAs) with sickle cell disease.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Interpret the screening tests needed for adolescents and young adults (AYAs) with sickle cell disease (SCD)
- Review common complications of SCD in AYAs with this condition
- Describe the contraceptive choices in girls and women with SCD
- Review management of priapism, both ischemic and stuttering, in males with SCD
- Discuss practical strategies in pain management for AYAs with SCD
- Identify disease-modifying therapies that are FDA-approved for the treatment of SCD
- Describe the primary gap in knowledge of reproductive issues for patients with SCD receiving hydroxyurea therapy
Faculty
- Emily Riehm Meier, MD, MSHS
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. This activity is provided for 0.25 contact hours related to pharmacotherapeutic content. Nurses should only claim credit for the actual time spent participating in the activity.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 5/27/2021 to 5/26/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202575.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Hemophilia in Pictures Details
Activity Title
Hemophilia in Pictures
Purpose Statement
The purpose of Hemophilia in Pictures is to provide basic knowledge about hemophilia through pictures and easy-to-understand information.
Educational Objectives
Hemophilia in Pictures has many goals. Please refer to the HIP Educators Guide to learn more about the educational goals for Educators as well as People with Hemophilia.
Target Audience
Hemophilia in Pictures is for hemophilia educators and people with hemophilia alike. The information is basic and is provided through pictures and easy-to-understand language, so it is accessible to anyone.
Topics/Content
This online learning module covers a range of topics, including an introduction to hemophilia, assessing and managing bleeds, treatment of bleeds, staying healthy and preventing bleeds, and venipuncture and home therapy.
Faculty w/ credentials
- Lara Oyesiku, Chair of the HIP Working Group and Nurse's Committee, England
- Martin Bedford, Educational Advisor, England
- Annie Gillham, Nurse Advisor, South Africa
- Dr. Peter Jones, Medical Advisor, England
- Kathy Mulder, Physiotherapy Advisor, Canada
- David Page, Educational Advisor, Canada
- Laurie Blackstock, WFH Education Officer
Date of Original Release
2005
Note
Upon launching the presentation, there are three handouts available for you to print or save for future reference: Educator Guide, Educator Glossary, and On Screen Notes.
To access the handouts, click on the paperclip icon located in the lower right portion of the presentation box.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
How Does Blood Clot? Details
Title
How Does Blood Clot?
Purpose Statement
The purpose of this activity is to enable the learner to improve understanding of and increase interest in the basic concepts involved in the complex coagulation process to ultimately improve patient care.
Educational Objectives
- Examine the coagulation process from the point of injury to clot resolution.
- Evaluate the platelet reaction step of normal hemostasis.
- Differentiate among the three coagulation pathways, including the various clotting factors that participate in hemostasis.
Target Audience
Nurses and other healthcare staff employed within or affiliated with the U.S. Hemophilia Treatment Center (HTC) network.
Topics/Content
An animated module illustrating the coagulation cascade.
Faculty w/ credentials
- Roshni Kulkarni, MD
- Usha M. Reddy, MD
- Bruce L. Evatt, MD
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Please note: This program requires FLASH PLAYER. If your computer does not have FLASH PLAYER, or does not allow such files to play, you will not be able to view this program. You will need to speak to your institutions Information Technology department about enabling or installing FLASH PLAYER onto your computer.
Hydroxyurea for the Treatment of Sickle Cell Disease
- Credits: 0.75 (ACCME), 0.75 (ANCC), 0.75 (AAPA)
- Expiration Date: July 8, 2022
Hydroxyurea for the Treatment of Sickle Cell Disease Details
Activity Number and Title
21HT50949 - Hydroxyurea for the Treatment of Sickle Cell Disease
Release Date
July 9, 2021
Expiration Date
5:00 PM Eastern, July 8, 2022
The estimated time to complete this activity is 45 minutes.
Purpose Statement
The purpose of this activity is to enable learners to enhance his or her knowledge about the complications of sickle cell disease and the importance of hydroxyurea in reducing or preventing those complications; as well as to gain familiarity with the 2014 NHLBI guidelines concerning hydroxyurea treatment for adults living with sickle cell disease.
Activity Description
This online educational activity reviews the most common complications of sickle cell disease and introduces the most efficacious therapy currently available to treat and prevent these complications, hydroxyurea. The author discusses the rational behind hydroxyurea as a therapy, its effectiveness, and national prescribing guidelines.
Target Audience
This enduring material is intended for physicians, physician assistants, nurses, nurse practitioners, and other health care providers who treat persons with sickle cell disease and wish to improve their knowledge of hydroxyurea as a treatment for sickle cell disease as well as hydroxyurea prescribing practices, with the aim of improving health outcomes among persons with sickle cell disease.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Describe the most common complications of sickle cell disease, including acute chest syndrome, vaso-occlusive pain crisis, and stroke
- Discuss the rationale behind hydroxyurea as a treatment for sickle cell disease and its effectiveness at preventing sickle cell-related complications
- Analyze the mechanism of action, dosing, side effects, contraindications, and monitoring of hydroxyurea therapy for sickle cell disease
- Review the 2014 NHLBI Guidelines for hydroxyurea treatment for persons living with sickle cell disease
Faculty
- Emily Riehm Meier, MD, MSHS
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. This activity is provided for 0.3 contact hours related to pharmacotherapeutic content. Nurses should only claim credit for the actual time spent participating in the activity.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid from 5/1/2021 to 5/2/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202570.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Physical Therapy and Comprehensive Care
- Credits: 0.75 (ANCC), 0.075 (CPTA)
- Expiration Date: June 15, 2023
Physical Therapy and Comprehensive Care Details
Activity Number and Title
20CE169 - Physical Therapy and Comprehensive Care
Release Date
June 15, 2021
Expiration Date
5:00 PM Eastern, June 15, 2023
NOTE: CPTA credit valid through June 15, 2022
The estimated time to complete this activity is 45 minutes.
Purpose Statement
The purpose of this module is to enable the learner to gain knowledge of the physical therapists role in providing comprehensive care at U.S. hemophilia treatment centers (HTCs), as well as the resources and opportunities available to physical therapists in the U.S. HTC network.
Activity Description
The activity begins with a brief description of the U.S. hemophilia treatment center (HTC) network and the comprehensive care model utilized at these centers. It then introduces the Physical Therapy Working Group (PTWG) of the National Hemophilia Foundation and resources available from this group, including recommendations on physical therapy evaluation elements as well as physical therapy treatment guidelines for bleeding disorder management. The activity also explains the physical therapists contribution to comprehensive care, including his or her role in helping patients select appropriate sports, physical activity, and employment.
Target Audience
This enduring material is intended for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, Understanding Hemophilia, prior to completion of this module on physical therapy and comprehensive care.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Discuss the history of the U.S. Hemophilia Treatment Center (HTC) network and the components of the multidisciplinary comprehensive care model employed by HTCs
- Explain the role of the Physical Therapy Working Group in the U.S. HTC network and resources available from this group
- Review funding opportunities available to physical therapists working in the U.S. HTC network
- Validate physical therapy as a key discipline in the multidisciplinary comprehensive care of people with bleeding disorders
- Discuss Physical Therapy Working Group guidelines for the management of bleeding disorders and the essential components of various team members roles within the comprehensive clinic as prescribed by the Physical Therapy Working Group
- Articulate the importance of sports and physical activity for persons with bleeding disorders and the physical therapists role in helping patients select appropriate activities
- Describe vocational considerations often discussed between the physical therapist and patient when treating persons with bleeding disorders
Faculty
- Stacie Akins, PT, MHS
- Kimberly Baumann, MPT
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center on behalf of the Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity (CPTA #21-362) has been approved by the California Physical Therapy Association (CPTA) for 0.075 CEUs. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Physical Therapy in the Care of Persons with Bleeding Disorders
- Credits: 1.5 (ANCC), 0.15 (CPTA)
- Expiration Date: June 15, 2023
Physical Therapy in the Care of Persons with Bleeding Disorders Details
Activity Number and Title
20CE168 - Physical Therapy in the Care of Persons with Bleeding Disorders
Release Date
June 15, 2021
Expiration Date
5:00 PM Eastern, June 15, 2023
NOTE: CPTA credit valid through June 15, 2022
The estimated time to complete this activity is 90 minutes.
Purpose Statement
The purpose of this online learning module is to enable the learner to increase their knowledge on the musculoskeletal concerns, potential complications, and physical therapy management of bleeding disorders.
Activity Description
After providing a review of basic information about hemophilia and von Willebrand disease, this learning module describes signs and symptoms of hemophilic bleeding, the complications associated with recurrent bleeding, physical therapy interventions for acute and chronic musculoskeletal complications of hemophilia, and imaging techniques including X-ray, MRI, and musculoskeletal ultrasound, which may be used to assess musculoskeletal status in patients with bleeding disorders.
Target Audience
This enduring material is intended for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, "Understanding Hemophilia", prior to completion of this module on physical therapy and comprehensive care.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Summarize basic information on the clinical picture of hemophilia and von Willebrand disease
- Identify signs and symptoms of acute and chronic musculoskeletal bleeding including hemarthroses and muscle bleeding
- Evaluate the complications of recurrent hemarthroses including chronic synovitis, cartilage destruction, and hemophilic arthropathy
- Discuss physical therapy interventions for acute bleeding events and chronic musculoskeletal complications of bleeding disorders and how the multidisciplinary team can help implement these strategies to improve patient outcomes
- Differentiate imaging techniques and their use to assess musculoskeletal status in patients with bleeding disorders
Faculty
- Stacie Akins, PT, MHS
- Kimberly Baumann, MPT
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center on behalf of the Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity (CPTA #21-361) has been approved by the California Physical Therapy Association (CPTA) for 0.15 CEUs. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
The Role of the Nurse in Hemophilia Care Details
Activity Title
The Role of the Nurse in Hemophilia Care
Purpose Statement
The purpose of this module is to familiarize the learner with the critical role nurses play worldwide in the multidisciplinary care team.
Educational Objectives
- Examine the critical and variable role of the nurse in the care of people with hemophilia.
- Review the role responsibilities of the nurse related to education, care delivery, coordination of the healthcare team, and support of patient and family to learn to live with hemophilia.
Topics/Content
While there are some responsibilities that are universal for all nurses, there is also a great deal of variation in the role and responsibilities of nurses in hemophilia care. This learning module describes those roles and responsibilities and some of the variation that may occur throughout the world.
Faculty w/ credentials
- World Federation of Hemophilia
Date of Original Release
June 18, 2013
Note
This module was created to describe the worldwide variation in the role and responsibilities of nurses in hemophilia care.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Accounting for Home Care: The Role of Treatment Logs in Bleeding Disorder Self-Management
- Credits: 0.75 (ANCC)
- Expiration Date: June 9, 2022
Accounting for Home Care: The Role of Treatment Logs in Bleeding Disorder Self-Management Details
Activity Number and Title
20CE057 - Accounting for Home Care: The Role of Treatment Logs in Bleeding Disorder Self-Management
Purpose Statement
This online learning activity aims to enable the learner to gain knowledge concerning the role and importance of treatment log-keeping for hemophilia home treatment; different types of treatment logs and their features; patient/provider viewpoints on treatment logs; and the clinical and research application of these logs.
Educational Objectives
- Review three variables associated with improved outcomes for persons with hemophilia
- Describe the initial concerns about home treatment of bleeding disorders and the underlying need to maintain a record of treatments administered
- Differentiate paper and electronic treatment logs
- Identify an application designed specifically for women with bleeding disorders to track symptoms of and treatments for heavy menstrual bleeding
- Examine the ideal features of a mobile application to improve self-management among persons with bleeding disorders
- Discuss patient viewpoints concerning treatment logs
- Introduce potential applications of treatment logs in clinical practice
Target Audience
Nurses, nurse practitioners, and other multidisciplinary hemophilia treatment center staff engaged in the care of persons with bleeding disorders who utilize home treatment to manage or prevent bleeding episodes
Topics/Content
This online learning activity is concerned with maintaining records of bleeding disorder treatments administered at home. It starts by describing the evolution of bleeding disorder treatment to the home and early providing concerns about home care. It then differentiates paper and electronic treatment log systems and lists several examples of both. It also identifies methods for tracking heavy menstrual bleeding and other symptoms among females with hemophilia and carriers. The activity goes on to consider the ideal features of a mobile application to improve self-management of persons with bleeding disorders. Finally, the activity discusses patient viewpoints on treatment logs and introduces potential applications of treatment logs in clinical practice.
Faculty w/ credentials
- Natalie Duncan, MPH
Date of Original Release
June 9, 2020
Expiration Date
5:00 PM Eastern, June 9, 2022
Method of Participation
The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 0.75 contact hours under ANCC criteria.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Hemophilia 101 for Nonclinical Staff at HTCs Details
Activity Title
Hemophilia 101 for Nonclinical Staff at HTCs (non CE)
Purpose Statement
This module is designed to provide information about the U.S. federally funded hemophilia treatment center (or HTC) network (referred to as USHTCN) and the multidisciplinary comprehensive care provided at HTCs. The module also reviews the key concepts of data collection and research at HTCs. Providing an overview of the scientific precepts of hemophilia, the module further explains how data and clinical care are integrated and pertinent to the important role of nonclinical staff at HTCs.
Educational Objectives
- Identify different parts of the federally funded U.S. HTC network
- Examine key components of the hemophilia comprehensive care model
- Review data collection requirements for linking the comprehensive care model to health outcomes
- Explain general scientific precepts of bleeding disorders
- Evaluate how data and clinical care are integrated and pertinent to the role of nonclinical staff
Target Audience
This module is designed for nonclinical professionals in the HTC network, including data collection personnel, administrators, HTC staff interacting with 340B programs.
Topics/Content
This module is divided into three sections:
Section I covers the U.S. Hemophilia Treatment Center Network (USHTCN) and the multidisciplinary comprehensive care model practiced at HTCs,
Section II reviews the data collection and research at HTCs, and
Section III discusses the clinical and medical issues in hemophilia at a 101 level and the importance of these issues to nonclinical staff.
Faculty w/ credentials
- Brenda Riske, MS, MBA, MPA
- Regina Butler, RN
- Jim Munn, RN, MS
Date of Original Release
January 30, 2015
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Hemophilia in History I: Early Accounts and Interventions
- Credits: 0.75 (ANCC)
- Expiration Date: June 1, 2022
Hemophilia in History I: Early Accounts and Interventions Details
Activity Number and Title
19CE063 - Hemophilia in History I: Early Accounts and Interventions
Purpose Statement
Upon completion of this program, the learner will be able to demonstrate knowledge of the early historical context that informs our modern understanding of hemophilia. Such knowledge is expected to enhance compassion of hemophilia providers toward patients and to facilitate high quality care.
Educational Objectives
- Interpret the historical records that represent the earliest known observations of hemophilia
- Differentiate the models of coagulation in terms of nomenclature utilized and pathways depicted
- Identify early compounds or products utilized in the treatment of hemophilia
- Explain the appearance, spread, and disappearance of hemophilia in the royal families of Europe
Target Audience
Clinical staff including nurses, social workers, physical therapists, pharmacists, and other multidisciplinary providers involved in the management of persons with hemophilia receiving care in the federally recognized U.S. Hemophilia Treatment Center (HTC) network
Topics/Content
This online learning activity includes discussion of the historical figures and events in early conceptions of hemophilia as a heritable bleeding diathesis, of the first models of coagulation, of unproven attempts to treat the condition, of the appearance of hemophilia in the royal families of Europe, and of the discoveries that led to our modern conception of and treatment products for hemophilia.
Faculty w/ credentials
- Natalie Duncan, MPH
- Jim Munn, MS, BS, BSN, RN-BC
- Susan Zappa, RN-BC, CPN
Date of Original Release
June 1, 2020
Expiration Date
5:00 PM Eastern, June 1, 2022
Method of Participation
The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 0.75 contact hours under ANCC criteria.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Hemophilia in History II: Factor Concentrates and Foundations of Comprehensive Care
- Credits: 0.5 (ANCC)
- Expiration Date: June 1, 2022
Hemophilia in History II: Factor Concentrates and Foundations of Comprehensive Care Details
Activity Number and Title
19CE064 - Hemophilia in History II: Factor Concentrates and Foundations of Comprehensive Care
Purpose Statement
Upon completion of this program, the learner will be able to demonstrate knowledge of the recent historical context in which our modern understanding of hemophilia and its management were developed. Such knowledge is expected to enhance compassion of hemophilia providers toward patients and to facilitate high quality care.
Educational Objectives
- Discuss the early development and evolution of clotting factor concentrates
- Describe the infectious disease contamination of the U.S. blood supply and its toll on the hemophilia community
- Review legislation passed in the wake of the hepatitis and HIV epidemics
- Examine the hemophilia treatment center model of care
- Identify three variables that contribute to prolonged life expectancy and improved quality of life among persons with hemophilia
Target Audience
Clinical staff including nurses, social workers, physical therapists, pharmacists, and other multidisciplinary providers involved in the management of persons with hemophilia receiving care in the federally recognized U.S. Hemophilia Treatment Center (HTC) network.
Topics/Content
This online learning activity includes discussion of the early development and evolution of clotting factor concentrates, the infectious disease contamination of the U.S. blood supply and its toll on the hemophilia community, as well as legislation that passed in the wake of the hepatitis and HIV epidemics. The activity also examines the hemophilia treatment center model of care. Finally, the module discusses the role of a safe blood supply, care from HTCs, and use of prophylactic therapy in prolonging life expectancy and enabling persons with hemophilia to lead increasingly normal lives.
Faculty w/ credentials
- Natalie Duncan, MPH
- Jim Munn, MS, BS, BSN, RN-BC
- Susan Zappa, RN-BC, CPN
Date of Original Release
June 1, 2020
Expiration Date
5:00 PM Eastern, June 1, 2022
Method of Participation
The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 0.5 contact hours under ANCC criteria.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Improving Access to Care Through Outreach
- Credits: 1.0 (ANCC), 1.0 (NASW)
- Expiration Date: October 31, 2021
Improving Access to Care Through Outreach Details
Activity Number and Title
20CE070 - Improving Access to Care Through Outreach
Purpose Statement
The purpose of this online learning activity is to enable the learner to develop competency in providing care through outreach and planning an outreach clinic.
Educational Objectives
- Discuss the impact of potential barriers to care and how to overcome these challenges including access to care in vulnerable populations
- Describe outreach as it relates to health care delivery and how various roles within a health care team are involved in the coordination process
- Differentiate three telemedicine delivery methods
- Discuss considerations involved in planning and financing an outreach clinic and potential cost-effectiveness of outreach
Target Audience
This module targets staff employed within the U.S. Hemophilia Treatment Center Network (USHTCN) to include nurses, nurse practitioners, social workers, physicians, physical therapists, administrators, and other professionals. It is also appropriate for hospital or institutional staff responsible for planning and managing outreach programs for persons with bleeding disorders.
Topics/Content
This online learning activity introduces outreach as a model of care, including telemedicine, and reviews logistical and cost considerations associated with planning an outreach clinic. Two detailed case studies enable the learner to apply information gained through this activity.
Faculty w/ credentials
- Irene S. Boehlefeld, BSN, RN-BC, CPHON
- Julia J. Golden, MSN, APRN
- Penelope (Penny) A. Kumpf, BSN, RN-BC
Date of Original Release
October 30, 2020
Expiration Date
5:00 PM Eastern October 31, 2021
Method of Participation
The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.0 contact hour under ANCC criteria.
This program is Approved by the National Association of Social Workers (Approval # 886604222-7940) for 1 continuing education contact hours.
The Indiana Hemophilia and Thrombosis Center is an approved provider of continuing social work education by the NASW CE Approval Program (Provider #886604222).
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
Nutritional Considerations in Common Comorbidities of Hemophilia
- Credits: 0.75 (ANCC)
- Expiration Date: May 22, 2023
Nutritional Considerations in Common Comorbidities of Hemophilia Details
Activity Number and Title
21HT00077 - Nutritional Considerations in Common Comorbidities of Hemophilia
Release Date
May 21, 2021
Expiration Date
5:00 PM Eastern, May 22, 2023
The estimated time to complete this activity is 45 minutes.
Purpose Statement
This online learning activity aims to enable learners to develop competencies regarding the roles and responsibilities of the Registered Dietitian Nutritionist as a member of the multidisciplinary comprehensive care team and to gain knowledge of nutritional considerations in common comorbidities of hemophilia, to include hepatitis C, HIV, iron deficiency anemia, osteoporosis, obesity, and dyslipidemia.
Activity Description
This learning activity introduces the RDN as a member of the extended hemophilia comprehensive care team at U.S. Hemophilia Treatment Centers (HTCs). Topics include discussion of the roles and responsibilities of the RDN or other qualified individual, components of the nutrition assessment administered by this professional, nutrition objectives and dietary interventions for common comorbidities of hemophilia, and important considerations and discussion points on use of dietary supplements among persons with hemophilia.
Target Audience
This online learning activity is intended for registered dietitian nutritionists, nurses, physical therapists, social workers, and other members of the multidisciplinary comprehensive care team at U.S. Hemophilia Treatment Centers, or HTCs, who are involved in or support the nutritional health of patients with hemophilia.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Discuss the roles and responsibilities of the Registered Dietitian Nutritionist on the hemophilia comprehensive care team
- Examine the components of the nutrition assessment administered by the Hemophilia Treatment Center Registered Dietitian Nutritionist
- Evaluate nutrition objectives and dietary interventions for common comorbidities of hemophilia
- Identify important considerations and discussion points for persons with hemophilia regarding dietary supplements
Faculty
- Tina Willis, MA, RDN
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Understanding Hemophilia
- Credits: 2.0 (ANCC), 2.00 (AAPA)
- Expiration Date: February 7, 2022
Understanding Hemophilia Details
Activity Number and Title
19CE096 - Understanding Hemophilia
Purpose Statement
"Understanding Hemophilia" is a 6-part online learning activity that aims to enable clinicians at U.S. Hemophilia Treatment Centers to gain knowledge and develop expertise on the pathogenesis, inheritance, symptoms, potential complications, and clinical management of hemophilia.
Educational Objectives
- Describe the pathogenesis and inheritance patterns concerning the different factor deficiencies in hemophilia including the symptoms and sequelae that may occur
- Discuss the target factor levels for situational bleeding episodes in conjunction with the appropriate factor replacement protocols, prophylactic treatments, and nursing considerations in administration of clotting factor concentrates
- Review the development and impact of inhibitors on persons with hemophilia, including signs and symptoms, risk factors, treatment implications, and nursing considerations
- Summarize the MASAC recommendations on the use of Emicizumab such as the indications, management approaches, and concurrent use with bypassing agents
- Articulate the role of genetic testing in the identification of potential carriers and women with hemophilia and the hemostatic management recommendations during pregnancy, labor and delivery, and the postpartum phases
Target Audience
This online learning activity is intended for nurses, nurse practitioners, physician assistants, and other clinical staff within the federally recognized U.S. Hemophilia Treatment Center (HTC) network who wish to develop an understanding of basic concepts of hemophilia. The activity is particularly appropriate for clinicians within their first six months of employment at an HTC.
Topics/Content
This 6-part online learning activity introduces basic concepts of hemophilia.
Part 1: Pathogenesis & Inheritance examines the coagulation system and processes, the deficit in hemophilia that interferes with clot formation, differences among types of hemophilia, and the sex-linked inheritance pattern of hemophilia.
Part 2: Symptoms & Sequelae distinguishes bleeding patterns and clinical presentation of hemophilia based on severity, differentiates types of bleeding episodes, and discusses physical/psychosocial sequelae of hemophilia.
Part 3: Factor Concentrates & Hemophilia Management discusses episodic and prophylactic management of hemophilia with clotting factor concentrate, different factor therapy protocols, and nursing considerations in administration of clotting factor concentrates.
Part 4: Introduction to Inhibitors explains the immune response and inhibitor development, signs/symptoms and risk factors of inhibitors, the impact of inhibitors on persons with hemophilia, inhibitor treatment strategies and challenges, and the positive health outcomes of immune tolerance induction therapy.
Part 5: Emicizumab covers the novel agent emicizumab, including its indications, mechanism of action, dosing options, lab considerations; as well as management of breakthrough bleeding, the boxed warning of emicizumab, use of emicizumab concurrently with bypassing agents, and potential considerations in the management of persons with hemophilia with or without inhibitors who utilize emicizumab.
Part 6: Carrier Considerations reviews hemophilia sex-linked genetics and introduces recommendations for the management of carriers and women with hemophilia, neonatal diagnosis and circumcision in males with hemophilia, and key considerations of postpartum management of carriers and women with hemophilia.
Faculty w/ credentials
- Jennifer Maahs, MSN, PNP, RN-BC
- Amy Shapiro, MD
Date of Original Release
February 7, 2020
Expiration Date
5:00 PM Eastern, February 7, 2022
Method of Participation
The estimated time to complete this activity is 120 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:
- Read the Program Announcement Form
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better.
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Centers Commission on Accreditation.
This activity is provided for 2.0 contact hours under ANCC criteria.
This activity is provided for 0.3 contact hours related to pharmacotherapeutic content.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. Approval is valid from 2/7/2021 to 2/7/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-201887.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218, toll-free 877-256-8837, or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
A School Nurse's Guide to Sickle Cell Disease
- Credits: 0.75 (ACCME), 0.75 (ANCC), 0.75 (AAPA)
- Expiration Date: July 8, 2022
A School Nurse's Guide to Sickle Cell Disease Details
Activity Number and Title
21HT00091 - A School Nurse's Guide to Sickle Cell Disease
Release Date
August 18, 2021
Expiration Date
5:00 PM Eastern, August 18, 2023
The estimated time to complete this activity is 30 minutes.
Purpose Statement
The purpose of this activity is to enable the learner to gain knowledge on the etiology, symptoms, treatment of sickle cell disease, and management strategies in order to optimize safety and learning for affected students.
Activity Description
This module will present the causes, disease traits, inheritance, and symptoms of sickle cell disease (SCD). In addition, common problems and complications of SCD including pain, stroke, priapism, acute chest syndrome, infection, bone disease, eye disease, and other health problems will be provided. Strategies and special accommodations that can be used in the school setting will also be presented.
Target Audience
This enduring material is intended for professional school nurses in schools attended by a child with sickle cell disease (SCD), teachers, physical education teachers, administrators and guidance counselors, and other school staff or health care professionals who require an introduction to school-related considerations for students with SCD.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Describe basic information related to the etiology and symptoms of sickle cell disease (SCD)
- Identify common challenges for students with SCD and interventions utilized within the school setting
- Integrate strategies and accommodations in the school setting to promote a safe and positive learning environment for students with SCD
Faculty
- Ellen Bloom, MPH, CHES
- Kisha Hampton, MPH
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Allison Lipps in Indianapolis, IN, 317-871-0011 ext. 218 or via email at alipps@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease - Accredited
- Credits: CNE, CME
- Expiration Date: October 16, 2021
Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease - Accredited Details
Activity Title
Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease
- Introduction (WD2833)
- Module 1. Use of Transfusion During Acute Illness (WD2943)
- Module 2. Delayed Hemolytic Transfusion Reactions (WD2944)
- Module 3. Management of Chronic Transfusion (WD2945)
About the Activity
Transfusion is an established therapy in sickle cell disease. It can treat and prevent certain disease complications, reducing morbidity and mortality; but there are unique aspects of transfusing individuals with sickle cell disease that must be taken into consideration to maximize benefits and minimize complications. In 2014, the National Heart Lung and Blood Institute of the National Institutes of Health released an expert panel report on sickle cell disease management that includes evidence-based recommendations for transfusion and the avoidance and management of transfusion complications. In addition, guidelines from Great Britain were published in 2017 addressing laboratory and clinical management of transfusion in sickle cell disease. This course presents these and other important aspects of quality, effective care for individuals with sickle cell disease.
Purpose Statement
Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders. Content is derived from actual peer-reviewed publications.
Educational Objectives
Introduction
- Describe the optimal hemoglobin level when transfusing a sickle cell patient
- List common reasons for transfusing individuals with sickle cell disease
- Recognize common complications of transfusion in sickle cell disease
- Locate current evidence-based recommendations for transfusion in sickle cell disease
Module 1. Use of Transfusion During Acute Illness (WD2943)
- Recognize indications for red blood cell transfusion during acute illness in individuals with sickle cell disease
- Describe appropriate selection of blood products for transfusion during acute illness in individuals with SCD
- Identify management strategies for acute splenic sequestration in SCD
- Describe indications for RBC transfusion prior to elective surgical procedures in SCD
Module 2. Delayed Hemolytic Transfusion Reactions (WD2944)
- Describe practice recommendations for transfusion in sickle cell disease patients with acute chest syndrome
- Explain the pathophysiology of delayed hemolytic transfusion reactions and hyperhemolysis
- List techniques for evaluating alloantibodies and DHTR
- Explain the assessment and management of DHTR
Module 3. Management of Chronic Transfusion (WD2945)
- Describe the role of chronic transfusion in preventing and managing certain complications of sickle cell disease
- Describe prevention and management of alloimmunization in individuals on chronic transfusion
- Describe the importance of iron overload in chronically transfused patients with sickle cell disease
- Describe the management of iron overload in patients on chronic transfusion
Target Audience
DOs, MDs, NPs, PAs
Faculty w/ credentials
Introduction
- James Eckman, M.D., Professor Emeritus of Hematology and Oncology, Emory University School of Medicine; Founding Director of the Comprehensive Sickle Cell Center at Grady Health System
Module 1. Use of Transfusion During Acute Illness (WD2943)
- Peter A. Lane, M.D., Professor of Pediatrics, Emory University School of Medicine; Director, Sickle Cell Disease Program, Children's Healthcare of Atlanta
Module 2. Delayed Hemolytic Transfusion Reactions (WD2944)
- Ross Fasano, MD, Assistant Professor in the Department of Laboratory Medicine, Emory University School of Medicine; Director of Apheresis and Pediatric Hematologist, Children's Healthcare of Atlanta
Module 3. Management of Chronic Transfusion (WD2945)
- James Eckman, MD, Professor Emeritus of Hematology and Oncology, Emory University School of Medicine; Founding Director of the Comprehensive Sickle Cell Center, Grady Health System
Important Dates
Origination Date: August 25, 2017
Renewal Date: October 16, 2019
Expiration Date: October 16, 2021
Unapproved Use Disclosure
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
Non-endorsement of Products
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Method of Participation
There are no fees for participating in and receiving credit for this activity. In order to receive credit,
- Complete the Provider Training Video Series at Georgia Health Policy Center
- Complete the evaluation at CDC Training and Continuing Education Online
- Pass the posttest at 75% (minimum score) at CDC Training and Continuing Education Online
Joint Providership Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and Georgia State University.
The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.
Accreditation Statement and Contact Hours
CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited (by the ACCME) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education (CNE) by the American Nurses Credentialing Center's Commission on Accreditation.
Please view individual training videos for information on accreditation and contact hours.
Financial Support
CDC did not accept commercial support for this continuing education activity.
Acknowledgment
Development of this course was supported by Cooperative Agreement DD14-1406, funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or Department of Health and Human Services.
Contact Information
If you have any questions about this activity, please contact Mary Hulihan PhD, Health Scientist, Epidemiology and Surveillance Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, at 404-498-6724.
System Requirements
- Computer hardware
- Internet connection
- Browser
The Partners in Bleeding Disorders Education Program is supported by educational grant from the National Hemophilia Foundation (NHF) and Takeda Pharmaceuticals U.S.A., Inc.
Copyright © 2021 Indiana Hemophilia & Thrombosis Center. All rights reserved. Privacy Policy | Travel Policy | Terms of Service Credits